Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility

Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility - Protective efficacy by zanamivir in a medical facility

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012799

Enrollment

100

Registered

2014-01-09

Start date

2014-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

prophylactic administration of zanamivir administration of pracebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the staff who; 1.works in Shizuoka Kosei Hospital and collaboration facilities 2.works the day shift 3.gives written informed concent

Exclusion criteria

Exclusion criteria: the staff who; 1.has specific medical history Ex.1 asthma Ex.2 other pulmonary diseases Ex.3 taking medications affecting immune system 2.shows difficulty in inhalation of zanamivir 3.is considered unsuitable by a responsibil doctor

Design outcomes

Primary

Measure	Time frame
incidence of influenza-like illness	—

Countries

Japan

Contacts

Public ContactToshihiro Tanaka

Shizuoka Kosei Hospital Department of Pediatrics

toshihiro.tanaka@alumni.utoronto.ca054-271-7177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026